Literature DB >> 25019057

Semen lactoferrin promotes CCL20 production by epithelial cells: Involvement in HIV transmission.

Alan Grupioni Lourenço1, Marilena Chinalli Komesu1, Alcyone Artioli Machado1, Silvana Maria Quintana1, Thomas Bourlet1, Bruno Pozzetto1, Olivier Delézay1.   

Abstract

AIM: To study the effect of seminal plasma on Chemokine (C-C motif) ligand 20 (CCL20) production by epithelial cells and its relationship with lactoferrin.
METHODS: HEC-1A cells, a cell line derived from a monostratified endocervical epithelium, were incubated with samples of seminal plasma (diluted 1:10 in culture medium) recovered from human immunodeficiency virus (HIV) seronegative (HIV-) or HIV seropositive (HIV+) subjects. Recombinant human interleukin 1 beta (IL-1β) was used as positive control, and culture medium only as negative control. The measurement of CCL20 production in the supernatants of HEC-1A cells and of lactoferrin in seminal plasma was determined by enzyme-linked immunosorbent assay techniques. A fractionation of seminal plasma proteins was performed by ion exchange chromatography on a pool of seminal plasma specimens from HIV- subjects. Each fraction was tested for its ability to stimulate the production of CCL20 by HEC-1A cells and for its lactoferrin concentration. The HIV viral load in seminal plasma samples from HIV+ patients was measured using the HIV-Monitor kit (Roche Diagnostic Systems, Branchburg, NJ, United States).
RESULTS: The positive control IL-1β was responsible for an increase of 11.36 ± 3.36 times in the production of CCL20. Stimulation of HEC-1A cells was performed in 34 seminal plasma samples (22 from HIV+ subjects and 12 from HIV- subjects). The mean production of CCL20 by HEC-1A in presence of seminal plasma from HIV- and HIV+ subjects was respectively 5.38 ± 0.91 and 7.57 ± 3.26 times higher than that obtained with the untreated cells (P < 0.05 between the two groups). Using the same 34 specimens of seminal plasma, no correlation was observed between the concentration of total proteins in seminal plasma and their ability to stimulate the secretion of CCL20 by HEC-1 cells. In contrast, the ability to produce CCL20 by HEC-1A cells correlated to the concentration of lactoferrin in the seminal plasma samples (r coefficient = 0.56; CI: 0.26-0.76; P < 0.001). After fractionation by ion exchange chromatography, the seminal plasma fractions exhibiting the highest concentrations of lactoferrin were responsible for the greatest stimulation of CCL20 production by HEC-1A cells (r coefficient = 0.89; CI: 0.78-0.95; P < 0.0001).
CONCLUSION: Lactoferrin present in seminal plasma correlated with an increased production of CCL20 by HEC-1A cells and therefore could facilitate HIV entry through the genital mucosa.

Entities:  

Keywords:  CCL20; Endocervical epithelial cells; Human immunodeficiency virus/acquired immunodeficiency syndrome; Lactoferrin; Seminal plasma; Sexual transmission

Year:  2014        PMID: 25019057      PMCID: PMC4087152          DOI: 10.5501/wjv.v3.i2.11

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  24 in total

1.  Small molecule lactoferrin with an inflammatory effect but no apparent antibacterial activity in mastitic mammary gland secretion.

Authors:  Ken-ichi Komine; Yumiko Komine; Toshinobu Kuroishi; Jin Kobayashi; Yoshiaki Obara; Katsuo Kumagai
Journal:  J Vet Med Sci       Date:  2005-07       Impact factor: 1.267

Review 2.  Early HIV-1 target cells in human vaginal and ectocervical mucosa.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2010-12-01       Impact factor: 3.886

3.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

4.  Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma.

Authors:  Yoshihiro Abiko; Michiko Nishimura; Kaoru Kusano; Keisuke Nakashima; Kazuhiko Okumura; Toshiya Arakawa; Taishin Takuma; Itaru Mizoguchi; Tohru Kaku
Journal:  Arch Oral Biol       Date:  2003-02       Impact factor: 2.633

Review 5.  Genital immunology and HIV susceptibility in young women.

Authors:  Tae Joon Yi; Brett Shannon; Jessica Prodger; Lyle McKinnon; Rupert Kaul
Journal:  Am J Reprod Immunol       Date:  2012-11-12       Impact factor: 3.886

Review 6.  The CC chemokine CCL20 and its receptor CCR6.

Authors:  Evemie Schutyser; Sofie Struyf; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

Review 7.  Sexually transmitted diseases, HIV, and AIDS in women.

Authors:  Susan E Cohn; Rebecca A Clark
Journal:  Med Clin North Am       Date:  2003-09       Impact factor: 5.456

Review 8.  Essential roles for dendritic cells in the pathogenesis and potential treatment of HIV disease.

Authors:  Vincent Piguet; Andrew Blauvelt
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551

9.  Distinct cytokine patterns in semen influence local HIV shedding and HIV target cell activation.

Authors:  Abraham J Olivier; Lindi Masson; Katharina Ronacher; Gerhard Walzl; David Coetzee; David A Lewis; Anna-Lise Williamson; Jo-Ann S Passmore; Wendy A Burgers
Journal:  J Infect Dis       Date:  2013-11-23       Impact factor: 5.226

10.  Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.

Authors:  Tanya Sperling; Monika Ołdak; Barbara Walch-Rückheim; Claudia Wickenhauser; John Doorbar; Herbert Pfister; Magdalena Malejczyk; Sławomir Majewski; Andrew C Keates; Sigrun Smola
Journal:  PLoS Pathog       Date:  2012-07-26       Impact factor: 6.823

View more
  1 in total

Review 1.  The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid.

Authors:  Anthonio Adefuye; Arieh Anthony Katz; Kurt Jason Sales
Journal:  Patholog Res Int       Date:  2014-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.